700
Participants
Start Date
February 23, 2021
Primary Completion Date
November 30, 2025
Study Completion Date
January 31, 2026
9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
Gardasil-9 HPV vaccine
Saline Placebo
Saline Placebo
Instituto Nacional de Salud Pública, Mexico, Cuernavaca
Universidade de São Paulo, São Paulo
University of Puerto Rico AIDS Clinical Trials Unit, San Juan
H. Lee Moffitt Cancer Center and Research Institute
OTHER
University of Sao Paulo
OTHER
University of Puerto Rico
OTHER
Instituto Nacional de Salud Publica, Mexico
OTHER
National Cancer Institute (NCI)
NIH
Merck Sharp & Dohme LLC
INDUSTRY
University of California, San Diego
OTHER
Weill Medical College of Cornell University
OTHER